INmune Bio Inc
NASDAQ:INMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
Pultegroup Inc
NYSE:PHM
|
US |
|
Keysight Technologies Inc
NYSE:KEYS
|
US |
|
S
|
Star7 SpA
MIL:STAR7
|
IT |
|
Hyundai Glovis Co Ltd
KRX:086280
|
KR |
|
Pebble Group PLC
LSE:PEBB
|
UK |
Wall St Price Targets
INMB Price Targets Summary
INmune Bio Inc
According to Wall Street analysts, the average 1-year price target for
INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INMB's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for INmune Bio Inc?
Projected CAGR
206%
The compound annual growth rate for Revenue over the next 8 years is 206%.